What is NDC 51662-1456?

51662-1456 is the product NDC for Bupivicaine Hydrochloride, Bupivacaine hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bupivicaine Hydrochloride?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bupivicaine Hydrochloride NDC 51662-1456

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1456Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1456Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1456-1	5166214560151662145601	30 mL in 1 VIAL, SINGLE-DOSE (51662-1456-1)Marketed from Dec 12, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupivicaine Hydrochloride
Generic name (nonproprietary): bupivicaine hydrochloride
Active ingredients: Bupivacaine hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration, Intracaudal, Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070583
Marketing start: Dec 12, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1456_b107e2b0-091e-b326-e053-2a95a90aa253SPL ID b107e2b0-091e-b326-e053-2a95a90aa253SPL set ID 99857946-6084-1bbd-e053-2a95a90af58cUNII 7TQO7W3VT8
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662145601 followed by a unit qualifier and the quantity

Package 51662-1456-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 6, 2020.

Indications (excerpt from the label)

INDICATIONS & USAGE Bupivacaine Hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (See WARNINGS) . Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of Bupivacaine Hydrochloride in these patients. Bupivacaine Hydrochloride is not recommended for intravenous regional anesthesia (Bier Block) (See WARNINGS ). The routes of administration and indicated Bupivacaine Hydrochloride co…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1456

What is NDC 51662-1456?: 51662-1456 is the product NDC for Bupivicaine Hydrochloride, Bupivacaine hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bupivicaine Hydrochloride.
What is the active ingredient?: Bupivacaine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bupivicaine Hydrochloride?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 070583

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070583
Product	Strength	Form · route	Labeler	Product NDC
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Hospira, Inc.	0409-1159
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Cardinal Health 107, LLC	55154-6970
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	ProPharma Distribution	84549-259
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Sportpharm LLC	85766-074